WO2021109006A1 - Medicinal liquid introduction head and penetration enhancement instrument - Google Patents

Medicinal liquid introduction head and penetration enhancement instrument Download PDF

Info

Publication number
WO2021109006A1
WO2021109006A1 PCT/CN2019/122809 CN2019122809W WO2021109006A1 WO 2021109006 A1 WO2021109006 A1 WO 2021109006A1 CN 2019122809 W CN2019122809 W CN 2019122809W WO 2021109006 A1 WO2021109006 A1 WO 2021109006A1
Authority
WO
WIPO (PCT)
Prior art keywords
introduction head
head body
introduction
working surface
head according
Prior art date
Application number
PCT/CN2019/122809
Other languages
French (fr)
Chinese (zh)
Inventor
徐百
Original Assignee
苏州纳生微电子有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 苏州纳生微电子有限公司 filed Critical 苏州纳生微电子有限公司
Publication of WO2021109006A1 publication Critical patent/WO2021109006A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Definitions

  • the nano-chips in the medicinal solution introduction head of the present invention are directly embedded on the working surface of the introduction head body, which avoids the combination of the introduction head body by means of glue, and overcomes the defects of the fixing method of glue. , Which facilitates the assembly and fixation of nano wafers.

Abstract

Disclosed is a medicinal liquid introduction head, comprising: an introduction head body, wherein an end face of one end thereof forms a working face, and the introduction head body is integrally formed by means of injection molding; and a nanometer wafer, which comprises a base and microneedles arranged on the base, wherein the nanometer wafer is directly embedded into a mounting groove formed during injection molding of the introduction head body, and the microneedles on the nanometer wafer protrude out of the working face. The nanometer wafer in the medicinal liquid introduction head of the present utility model is directly embedded into the working face of the introduction head body, and avoids the combination of same with the introduction head body by means of an adhesive, thereby overcoming the defect occurring when the nanometer wafer is fixed by means of the adhesive, and facilitating the assembly and fixation of the nanometer wafer.

Description

药液导入头及促渗仪Liquid drug introduction head and penetration enhancer 技术领域Technical field
本实用新型涉及透皮给药技术领域,具体地是涉及一种药液导入头及促渗仪。The utility model relates to the technical field of transdermal drug delivery, in particular to a medicinal solution introduction head and a permeation promoting instrument.
背景技术Background technique
目前在透皮给药技术领域,纳米微针或纳米晶片正被广泛应用。其中纳米晶片是根据人体皮肤结构开发的纳米促渗专用工具,它是由单晶硅经过纳米技术工艺雕刻而成。纳米晶片的表面是一系列微针阵列,它们可以打开皮肤最外面的角质层,同时不会伤及真皮层,大大提高药物的渗透能力。单晶硅的生物兼容性又保证了纳晶在使用过程中的安全性。现有的纳米微针或纳米晶片主要通过粘胶的方式固定于储药容器上,然而上述结合方式,粘胶容易外溢而出,进而影响使用。因此,针对上述问题,有必要提出进一步地解决方案。At present, in the field of transdermal drug delivery technology, nano-microneedles or nano-chips are being widely used. Among them, the nano-chip is a special tool for nano-infiltration enhancement developed based on the structure of human skin. It is carved from monocrystalline silicon through a nano-technology process. The surface of the nanochip is a series of microneedle arrays, which can open the outermost stratum corneum of the skin without damaging the dermis, greatly improving the penetration of drugs. The biocompatibility of monocrystalline silicon ensures the safety of nanocrystalline during use. The existing nano-microneedles or nano-chips are mainly fixed on the medicine storage container by means of glue. However, in the above-mentioned combination method, the glue is easy to spill out, thereby affecting the use. Therefore, it is necessary to propose further solutions to the above-mentioned problems.
实用新型内容Utility model content
本实用新型旨在提供一种药液导入头及促渗仪,以克服现有技术中存在的不足。The utility model aims to provide a medicinal liquid introduction head and a permeation enhancer to overcome the deficiencies in the prior art.
为解决上述技术问题,本实用新型的技术方案是:In order to solve the above technical problems, the technical solution of the present utility model is:
一种药液导入头,其包括:A medicinal liquid introduction head, which comprises:
导入头本体,其一端的端面形成工作面,所述导入头本体通过注塑的方式一体成型;The introduction head body, the end surface of one end thereof forms a working surface, and the introduction head body is integrally formed by injection molding;
纳米晶片,其包括底座及设置于所述底座上的微针,所述纳米晶片直接嵌入到所述导入头本体注塑时形成的安装槽中,且所述纳米晶片上的微针突伸于所述工作面设置。A nanochip includes a base and a microneedle arranged on the base. The nanochip is directly embedded in the mounting groove formed during injection molding of the introduction head body, and the microneedles on the nanochip protrude from the base. The working surface settings are described.
作为本实用新型的药液导入头的改进,所述导入头本体内部中空设置,所述工作面上设置有与导入头本体内部相连通的出液孔。As an improvement of the liquid medicine introducing head of the present invention, the inside of the introducing head body is hollow, and the working surface is provided with a liquid outlet hole communicating with the inside of the introducing head body.
作为本实用新型的药液导入头的改进,所述出液孔为多个,多个出液孔分布于所述纳米晶片的四周。As an improvement of the medicinal liquid introduction head of the present invention, there are a plurality of the liquid outlet holes, and the plurality of liquid outlet holes are distributed around the nano wafer.
作为本实用新型的药液导入头的改进,所述导入头本体一端还安装有保护盖,所述纳米晶片及工作面收容于所述保护盖限定的空间中。As an improvement of the medicinal solution introduction head of the present invention, a protective cover is also installed at one end of the introduction head body, and the nano wafer and the working surface are accommodated in the space defined by the protective cover.
作为本实用新型的药液导入头的改进,所述导入头本体一端的外周壁面上设置有外螺纹,所述保护盖通过所述外螺纹旋接于所述导入头本体的一端。As an improvement of the liquid medicine introduction head of the present invention, an external thread is provided on the outer peripheral wall surface of one end of the introduction head body, and the protective cover is screwed to one end of the introduction head body through the external thread.
作为本实用新型的药液导入头的改进,所述纳米晶片于所述导入头本体注塑成型时同步地嵌入到所述导入头本体的工作面中。As an improvement of the medicinal solution introduction head of the present invention, the nano wafers are synchronously embedded into the working surface of the introduction head body during injection molding of the introduction head body.
作为本实用新型的药液导入头的改进,所述纳米晶片于所述导入头本体注塑成型后,固化之前嵌入到所述导入头本体的工作面中。As an improvement of the medicinal solution introduction head of the present invention, the nano wafer is embedded in the working surface of the introduction head body after injection molding of the introduction head body and before solidification.
作为本实用新型的药液导入头的改进,所述导入头本体的周向外侧壁上还设置有卡合结构,所述卡合结构为设置于所述外侧壁上的凸起或者凹陷。As an improvement of the medicinal solution introduction head of the present invention, the introduction head body is also provided with a snap structure on the peripheral outer side wall, and the snap structure is a protrusion or depression provided on the outer side wall.
作为本实用新型的药液导入头的改进,所述导入头本体的材质为避光材料。As an improvement of the liquid medicine introduction head of the present invention, the material of the introduction head body is a light-proof material.
为解决上述技术问题,本实用新型的技术方案是:In order to solve the above technical problems, the technical solution of the present utility model is:
一种促渗仪,其包括:外壳、安装于所述外壳给药端的如上所述的药液导入头。A permeation enhancer, comprising: a housing, and the above-mentioned medicinal solution introduction head installed at the administration end of the housing.
与现有技术相比,本实用新型的有益效果是:本实用新型的药液导入头中纳米晶片直接嵌入到导入头本体工作面上,其避免了通过粘胶的方式与导入头本体相结合,克服了粘胶方式固定时的缺陷,方便了纳米晶片的组装固定。Compared with the prior art, the beneficial effect of the present invention is that the nano-chip in the medicinal liquid introduction head of the present invention is directly embedded on the working surface of the introduction head body, which avoids the combination with the introduction head body by means of glue. , Overcoming the defects of glue fixation, and facilitating the assembly and fixation of nano-chips.
附图说明Description of the drawings
图1为本实用新型所述的药液导入头一实施例的立体示意图;Fig. 1 is a three-dimensional schematic diagram of an embodiment of the medicinal liquid introduction head according to the utility model;
图2为本实用新型所述的促渗仪一实施例的主视图。Figure 2 is a front view of an embodiment of the permeation enhancer according to the present invention.
具体实施方式Detailed ways
下面将结合本实用新型实施例中的附图,对本实用新型实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本实用新型一部分实施例,而不是全部的实施例。基于本实用新型中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本实用新型保护的范围。The following will clearly and completely describe the technical solutions in the embodiments of the present utility model with reference to the accompanying drawings in the embodiments of the present utility model. Obviously, the described embodiments are only a part of the embodiments of the present utility model, not all implementations. example. Based on the embodiments of the present utility model, all other embodiments obtained by those of ordinary skill in the art without creative work shall fall within the scope of protection of the present utility model.
如图1所示,本实用新型提供一种药液导入头100,其包括:导入头本体1和纳米晶片2。As shown in FIG. 1, the present invention provides a medical liquid introduction head 100, which includes: an introduction head body 1 and a nano wafer 2.
所述导入头本体1内部中空设置,如此使得该导入头本体1可作为药液的存放容器使用。所述导入头本体1一端的端面形成工作面。为了方便出液,相应的,所述工作面上设置有与导入头本体1内部相连通的出液孔11。从而,当导入头本体1中存放有药液时,药液能够自出液孔11流出实现供药。一个实施方式中,所述出液孔11为多个,多个出液孔11分布于所述纳米晶片2的四周,如此以实现药物的均匀供给。The introduction head body 1 is hollow inside, so that the introduction head body 1 can be used as a storage container for liquid medicine. The end surface of one end of the introduction head body 1 forms a working surface. In order to facilitate the liquid discharge, correspondingly, a liquid discharge hole 11 communicating with the inside of the introduction head body 1 is provided on the working surface. Therefore, when the liquid medicine is stored in the introduction head body 1, the liquid medicine can flow out from the liquid outlet hole 11 to realize the medicine supply. In one embodiment, there are a plurality of the liquid outlet holes 11, and the plurality of liquid outlet holes 11 are distributed around the nanochip 2 so as to realize uniform supply of medicine.
成型方式上,所述导入头本体1通过注塑的方式一体成型。一个实施方式中,所述导入头本体1采用避光材料,如此避免存放于导入头本体1中的药液发生性状变化。In terms of the molding method, the introduction head body 1 is integrally molded by injection molding. In one embodiment, the introduction head body 1 is made of light-shielding materials, so as to prevent the medicinal solution stored in the introduction head body 1 from changing properties.
所述纳米晶片2包括底座及设置于所述底座上的微针。The nanochip 2 includes a base and microneedles arranged on the base.
其中,所述纳米晶片2是根据人体皮肤结构开发的纳米促渗专用工具,它是由单晶硅经过纳米技术工艺雕刻而成。纳米晶片的表面是一系列阵列排布的微针,它们可以打开皮肤最外面的角质层,同时不会伤及真皮层,大大提高药物的渗透能力。Wherein, the nano-chip 2 is a special tool for nano-penetration enhancement developed according to the structure of human skin, and it is carved from monocrystalline silicon through nano-technology. The surface of the nanochip is a series of microneedles arranged in an array, which can open the outermost stratum corneum of the skin without damaging the dermis, greatly improving the penetration ability of drugs.
所述纳米晶片2直接嵌入到所述导入头本体1注塑时形成的安装槽中,且所述纳米晶片2上的微针突伸于所述工作面设置。此时,所述纳米晶片2 与导入头本体1相接触的表面与导入头本体1之间能够相互渗透进而结合的更加紧固。如此,避免了通过粘胶的方式与导入头本体1相结合,克服了粘胶方式固定时的缺陷,方便了纳米晶片2的组装固定。The nanochip 2 is directly embedded in the mounting groove formed during injection molding of the introduction head body 1, and the microneedles on the nanochip 2 protrude from the working surface. At this time, the surface of the nano wafer 2 in contact with the introduction head body 1 and the introduction head body 1 can infiltrate each other to be more securely combined. In this way, the combination with the introduction head body 1 by means of glue is avoided, the defects of fixing by means of glue are overcome, and the assembly and fixing of the nanochip 2 is facilitated.
为了实现所述纳米晶片2与导入头本体1之间的相互渗透,所述纳米晶片2于所述导入头本体1注塑成型时同步地嵌入到所述导入头本体1的工作面中。可替代地,所述纳米晶片2也可于所述导入头本体1注塑成型后,固化之前嵌入到所述导入头本体1的工作面中。上述两种组装方式,由于导入头本体1未完全固化成型,且自身温度较高,纳米晶片2与导入头本体1之间接触的表面能够相互渗透融合,实现牢固地结合。In order to achieve mutual penetration between the nano wafer 2 and the introduction head body 1, the nano wafer 2 is synchronously embedded into the working surface of the introduction head body 1 during injection molding of the introduction head body 1. Alternatively, the nano wafer 2 may also be embedded in the working surface of the introduction head body 1 after injection molding of the introduction head body 1 and before curing. In the above-mentioned two assembly methods, since the introduction head body 1 is not completely cured and formed, and its own temperature is relatively high, the contact surfaces between the nano wafer 2 and the introduction head body 1 can penetrate and fuse with each other to achieve a firm combination.
为了对纳米晶片2及工作面进行保护,以及防止导入头本体1中存放的药液漏出,所述导入头本体1一端还安装有保护盖3,所述纳米晶片2及工作面收容于所述保护盖3限定的空间中。此时,所述保护盖3相对所述工作面的一面压在出液孔11上,相应的,所述保护盖3相对所述工作面的一面还设置有收容所述伸出的纳米晶片2的容置腔。In order to protect the nano wafer 2 and the working surface, and prevent the liquid stored in the introduction head body 1 from leaking, a protective cover 3 is also installed at one end of the introduction head body 1, and the nano wafer 2 and the working surface are accommodated in the In the space defined by the protective cover 3. At this time, the side of the protective cover 3 opposite to the working surface is pressed on the liquid outlet hole 11. Correspondingly, the side of the protective cover 3 opposite to the working surface is also provided with the protruding nano-chip 2 The housing cavity.
为了实现所述保护盖3的固定,一个实施方式中,所述导入头本体1一端的外周壁面上设置有外螺纹,所述保护盖3通过所述外螺纹旋接于所述导入头本体1的一端。在其他实施方式中,所述导入头本体1也可通过卡扣的方式套装在所述导入头本体1的一端。In order to realize the fixing of the protective cover 3, in one embodiment, an external thread is provided on the outer peripheral wall surface of one end of the introduction head body 1, and the protective cover 3 is screwed to the introduction head body 1 through the external threads. One end. In other embodiments, the introduction head body 1 can also be fitted on one end of the introduction head body 1 in a snap-fit manner.
如图2所示,基于上述药液导入头100,本实用新型还提供一种采用该药液导入头100的促渗仪200。具体地,所述促渗仪200包括:外壳201、安装于所述外壳201给药端的如上所述的药液导入头100。As shown in FIG. 2, based on the above-mentioned liquid medicine introduction head 100, the present invention also provides a permeation enhancer 200 using the liquid medicine introduction head 100. Specifically, the permeation enhancer 200 includes a housing 201, and the above-mentioned medicinal solution introduction head 100 installed on the drug delivery end of the housing 201.
为了方便外壳201与药液导入头100之间的连接固定,所述导入头本体1的周向外侧壁上还设置有卡合结构12,所述卡合结构12为设置于所述外侧壁上的凸起或者凹陷。其中,当所述卡合结构12为设置于所述外侧壁上的凸起时,所述外壳201的给药端的内腔中对应的位置设置有与该凸起相配合的卡 槽;当所述卡合结构12为设置于所述外侧壁上的凹陷时,所述外壳201的给药端的内腔中对应的位置设置有与该凸起相配合的卡扣。如此,当该药液导入头100使用完毕后,可将其取下抛弃,更换新的药液导入头100,方便了用户的使用。In order to facilitate the connection and fixation between the housing 201 and the medicinal solution introduction head 100, the introduction head body 1 is also provided with an engaging structure 12 on the peripheral outer side wall, and the engaging structure 12 is arranged on the outer side wall. The bulge or depression. Wherein, when the engaging structure 12 is a protrusion provided on the outer side wall, a corresponding position in the inner cavity of the drug delivery end of the housing 201 is provided with a card slot matching the protrusion; When the engaging structure 12 is a recess provided on the outer side wall, a corresponding position in the inner cavity of the drug delivery end of the housing 201 is provided with a buckle matching the protrusion. In this way, when the liquid medicine introduction head 100 is used up, it can be removed and discarded, and the liquid medicine introduction head 100 can be replaced with a new one, which is convenient for the user to use.
综上所述,本实用新型的药液导入头中纳米晶片直接嵌入到导入头本体工作面上,其避免了通过粘胶的方式与导入头本体相结合,克服了粘胶方式固定时的缺陷,方便了纳米晶片的组装固定。To sum up, the nano-chips in the medicinal solution introduction head of the present invention are directly embedded on the working surface of the introduction head body, which avoids the combination of the introduction head body by means of glue, and overcomes the defects of the fixing method of glue. , Which facilitates the assembly and fixation of nano wafers.
对于本领域技术人员而言,显然本实用新型不限于上述示范性实施例的细节,而且在不背离本实用新型的精神或基本特征的情况下,能够以其他的具体形式实现本实用新型。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本实用新型的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本实用新型内。不应将权利要求中的任何附图标记视为限制所涉及的权利要求。For those skilled in the art, it is obvious that the present invention is not limited to the details of the above exemplary embodiments, and the present invention can be implemented in other specific forms without departing from the spirit or basic characteristics of the present invention. Therefore, no matter from which point of view, the embodiments should be regarded as exemplary and non-limiting. The scope of the present invention is defined by the appended claims rather than the above description, and therefore it is intended to fall on the rights. All the changes in the meaning and scope of the required equivalent elements are included in the present invention. Any reference signs in the claims should not be regarded as limiting the claims involved.
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。In addition, it should be understood that although this specification is described in accordance with the implementation manners, not each implementation manner only includes an independent technical solution. This narration in the specification is only for the sake of clarity, and those skilled in the art should regard the specification as a whole The technical solutions in the various embodiments can also be appropriately combined to form other implementations that can be understood by those skilled in the art.

Claims (10)

  1. 一种药液导入头,其特征在于,所述药液导入头包括:A liquid medicine introducing head, characterized in that the liquid medicine introducing head comprises:
    导入头本体,其一端的端面形成工作面,所述导入头本体通过注塑的方式一体成型;The introduction head body, the end surface of one end thereof forms a working surface, and the introduction head body is integrally formed by injection molding;
    纳米晶片,其包括底座及设置于所述底座上的微针,所述纳米晶片直接嵌入到所述导入头本体注塑时形成的安装槽中,且所述纳米晶片上的微针突伸于所述工作面设置。A nanochip includes a base and a microneedle arranged on the base. The nanochip is directly embedded in the mounting groove formed during injection molding of the introduction head body, and the microneedles on the nanochip protrude from the base. The working surface settings are described.
  2. 根据权利要求1所述的药液导入头,其特征在于,所述导入头本体内部中空设置,所述工作面上设置有与导入头本体内部相连通的出液孔。The liquid medicine introducing head according to claim 1, wherein the inside of the introducing head body is hollow, and the working surface is provided with a liquid outlet hole communicating with the inside of the introducing head body.
  3. 根据权利要求2所述的药液导入头,其特征在于,所述出液孔为多个,多个出液孔分布于所述纳米晶片的四周。The liquid medicine introduction head according to claim 2, wherein the liquid outlet holes are multiple, and the multiple liquid outlet holes are distributed around the nano wafer.
  4. 根据权利要求1至3任一项所述的药液导入头,其特征在于,所述导入头本体一端还安装有保护盖,所述纳米晶片及工作面收容于所述保护盖限定的空间中。The medicinal solution introduction head according to any one of claims 1 to 3, wherein a protective cover is installed at one end of the introduction head body, and the nanochip and the working surface are accommodated in the space defined by the protective cover .
  5. 根据权利要求4所述的药液导入头,其特征在于,所述导入头本体一端的外周壁面上设置有外螺纹,所述保护盖通过所述外螺纹旋接于所述导入头本体的一端。The medicinal solution introduction head according to claim 4, wherein the outer peripheral wall surface of one end of the introduction head body is provided with an external thread, and the protective cover is screwed to one end of the introduction head body through the external thread .
  6. 根据权利要求1所述的药液导入头,其特征在于,所述纳米晶片于所述导入头本体注塑成型时同步地嵌入到所述导入头本体的工作面中。The medical solution introduction head according to claim 1, wherein the nano wafer is synchronously embedded into the working surface of the introduction head body during injection molding of the introduction head body.
  7. 根据权利要求1所述的药液导入头,其特征在于,所述纳米晶片于所述导入头本体注塑成型后,固化之前嵌入到所述导入头本体的工作面中。The liquid medicine introduction head according to claim 1, wherein the nano wafer is embedded in the working surface of the introduction head body after injection molding of the introduction head body and before solidification.
  8. 根据权利要求1所述的药液导入头,其特征在于,所述导入头本体的周向外侧壁上还设置有卡合结构,所述卡合结构为设置于所述外侧壁上的凸起或者凹陷。The medicinal solution introduction head according to claim 1, wherein an engaging structure is further provided on the peripheral outer side wall of the introduction head body, and the engaging structure is a protrusion provided on the outer side wall. Or recessed.
  9. 根据权利要求1所述的药液导入头,其特征在于,所述导入头本体的材质为避光材料。The medical solution introduction head according to claim 1, wherein the material of the introduction head body is a light-proof material.
  10. 一种促渗仪,其特征在于,所述促渗仪包括:外壳、安装于所述外壳给药端的如权利要求1-9任一项所述的药液导入头。A permeation enhancer, characterized in that, the permeation enhancer comprises: a housing, and the medicinal solution introduction head according to any one of claims 1-9 installed on the drug delivery end of the housing.
PCT/CN2019/122809 2019-12-02 2019-12-03 Medicinal liquid introduction head and penetration enhancement instrument WO2021109006A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201922124254.5U CN211675890U (en) 2019-12-02 2019-12-02 Liquid medicine leading-in head and penetration promoting instrument
CN201922124254.5 2019-12-02

Publications (1)

Publication Number Publication Date
WO2021109006A1 true WO2021109006A1 (en) 2021-06-10

Family

ID=72789135

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/122809 WO2021109006A1 (en) 2019-12-02 2019-12-03 Medicinal liquid introduction head and penetration enhancement instrument

Country Status (2)

Country Link
CN (1) CN211675890U (en)
WO (1) WO2021109006A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN215995286U (en) * 2021-09-30 2022-03-11 何现林 Water light needle and water light gun

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100060222A (en) * 2008-11-27 2010-06-07 김양수 Device for skin beauty and medical treatment
US20110172637A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including tissue support structure
CN103263727A (en) * 2013-05-22 2013-08-28 清华大学 Metal microneedle array, percutaneous medicine feeding paster, Dermaroller and microneedle electrode array
CN107362442A (en) * 2017-08-31 2017-11-21 珠海云动光电科技有限公司 Crystallite head and micro-needle cosmetic instrument
CN209490376U (en) * 2018-12-06 2019-10-15 苏州纳通生物纳米技术有限公司 Medical fluid imports head and drug delivery device
CN209500522U (en) * 2018-09-12 2019-10-18 苏州纳通生物纳米技术有限公司 Transdermal administration device
CN110368576A (en) * 2019-08-23 2019-10-25 苏州纳生微电子有限公司 Quantitative liquid feedway

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100060222A (en) * 2008-11-27 2010-06-07 김양수 Device for skin beauty and medical treatment
US20110172637A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including tissue support structure
CN103263727A (en) * 2013-05-22 2013-08-28 清华大学 Metal microneedle array, percutaneous medicine feeding paster, Dermaroller and microneedle electrode array
CN107362442A (en) * 2017-08-31 2017-11-21 珠海云动光电科技有限公司 Crystallite head and micro-needle cosmetic instrument
CN209500522U (en) * 2018-09-12 2019-10-18 苏州纳通生物纳米技术有限公司 Transdermal administration device
CN209490376U (en) * 2018-12-06 2019-10-15 苏州纳通生物纳米技术有限公司 Medical fluid imports head and drug delivery device
CN110368576A (en) * 2019-08-23 2019-10-25 苏州纳生微电子有限公司 Quantitative liquid feedway

Also Published As

Publication number Publication date
CN211675890U (en) 2020-10-16

Similar Documents

Publication Publication Date Title
US11633580B2 (en) Applicator for water-soluble sheet-shaped preparation
US10384047B2 (en) Hollow microneedle with bevel opening
US10099043B2 (en) Hollow microneedle array article
WO2020218486A1 (en) Applicator 2 of water-soluble sheet-like formulation
US20120109067A1 (en) Transdermal administration device
US10918845B2 (en) Transdermal administration device
CN103157178B (en) Seal type tool capable of accurately controlling microneedle insertion length
WO2016072060A1 (en) Microneedle set
US20170239458A1 (en) Transdermal administration devices and methods for producing transdermal administration devices
KR20070018410A (en) Transdermal patch having micro-scale needle array and method for manufacturing the same
JP5928661B2 (en) Acicular body
JP5746101B2 (en) Rapid dissolution method of microneedles
WO2021109006A1 (en) Medicinal liquid introduction head and penetration enhancement instrument
CN104117136A (en) Metal micro-needle array with medicine grooves and micro-needle percutaneous dosing patch and device
WO2021109005A1 (en) Drug administration connector and drug administration device
WO2020114403A1 (en) Medicinal liquid introduction head and drug delivery device
JP6003338B2 (en) Acicular package
KR102425556B1 (en) Microneedle assembly
US20150094664A1 (en) Drug delivery device
US20160082239A1 (en) Microneedle array and microneedle array device
WO2020114402A1 (en) Massage head and device for skin administration
JP3185527U (en) Board end face shape
JP2015136527A (en) Microneedle unit
JP2014128711A (en) Rapid dissolution method for microneedle
KR20110113797A (en) Percutaneous injection module

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19955263

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19955263

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 19955263

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 19/01/2023)

122 Ep: pct application non-entry in european phase

Ref document number: 19955263

Country of ref document: EP

Kind code of ref document: A1